pyrimethamine has been researched along with Cyst in 4 studies
Maloprim: contains above 2 cpds
| Excerpt | Relevance | Reference |
|---|---|---|
| "A substantial reduction of brain cyst numbers could be obtained through a six week therapy with SDDS-pyrimethamine combination or a high titer anti-Toxoplasma serum." | 7.65 | The effect of chemo-immunotherapy with SDDS, pyrimethamine and anti-toxoplasma serum on toxoplasma gondii cysts in latent infected NMRI mice. ( Adusu, E; Masihi, KN; Tischer, I; Werner, H, 1977) |
| "Treatment with pyrimethamine decreases cell proliferation in human ADPKD cells and blocks renal cyst formation in an adult and a neonatal PKD mouse model." | 5.37 | Pyrimethamine inhibits adult polycystic kidney disease by modulating STAT signaling pathways. ( Frank, DA; Haque, N; Humphreys, BD; Nelson, EA; Takakura, A; Zandi-Nejad, K; Zhou, J, 2011) |
| "A substantial reduction of brain cyst numbers could be obtained through a six week therapy with SDDS-pyrimethamine combination or a high titer anti-Toxoplasma serum." | 3.65 | The effect of chemo-immunotherapy with SDDS, pyrimethamine and anti-toxoplasma serum on toxoplasma gondii cysts in latent infected NMRI mice. ( Adusu, E; Masihi, KN; Tischer, I; Werner, H, 1977) |
| "Treatment with pyrimethamine decreases cell proliferation in human ADPKD cells and blocks renal cyst formation in an adult and a neonatal PKD mouse model." | 1.37 | Pyrimethamine inhibits adult polycystic kidney disease by modulating STAT signaling pathways. ( Frank, DA; Haque, N; Humphreys, BD; Nelson, EA; Takakura, A; Zandi-Nejad, K; Zhou, J, 2011) |
| "The activity of the macrolide antibiotic clarithromycin was examined alone or in combination with other drugs for the treatment of acute or chronic infections with Toxoplasma gondii in mice." | 1.28 | Activity of clarithromycin alone or in combination with other drugs for treatment of murine toxoplasmosis. ( Araujo, FG; Lin, T; Prokocimer, P; Remington, JS, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Takakura, A | 1 |
| Nelson, EA | 1 |
| Haque, N | 1 |
| Humphreys, BD | 1 |
| Zandi-Nejad, K | 1 |
| Frank, DA | 1 |
| Zhou, J | 1 |
| Werner, H | 1 |
| Masihi, KN | 1 |
| Tischer, I | 1 |
| Adusu, E | 1 |
| Faruqui, AM | 1 |
| Frank, M | 1 |
| Rosvoll, RV | 1 |
| Thebaut, B | 1 |
| Araujo, FG | 1 |
| Prokocimer, P | 1 |
| Lin, T | 1 |
| Remington, JS | 1 |
4 other studies available for pyrimethamine and Cyst
| Article | Year |
|---|---|
Pyrimethamine inhibits adult polycystic kidney disease by modulating STAT signaling pathways.
Topics: Adult; Aminosalicylic Acids; Animals; Animals, Newborn; Benzenesulfonates; Cell Line; Cysts; Disease | 2011 |
The effect of chemo-immunotherapy with SDDS, pyrimethamine and anti-toxoplasma serum on toxoplasma gondii cysts in latent infected NMRI mice.
Topics: Animals; Brain Diseases; Cysts; Dapsone; Female; Immunotherapy; Mice; Mice, Inbred Strains; Pyrimeth | 1977 |
Acute acquired toxoplasmosis.
Topics: Acute Disease; Age Factors; Cysts; Fever of Unknown Origin; Humans; Lymph Nodes; Lymphadenitis; Male | 1976 |
Activity of clarithromycin alone or in combination with other drugs for treatment of murine toxoplasmosis.
Topics: Acquired Immunodeficiency Syndrome; Acute Disease; Animals; Brain Diseases; Chronic Disease; Clarith | 1992 |